The importance of a properly functioning governance board is more relevant today than ever with the significant changes taking place in the healthcare market. Host Jeff Voigt leads a panel discussion on how these changes to health care relate to issues such as disruptions in reimbursement, effects on disruptive technologies such as gene therapy, and the rapid consolidation of both providers and payers – and antitrust issues related to this – on The Business of Health Care.
Panelists include: Jonathan Kalodimos, Ph.D., Assistant Professor of Finance at Oregon State University’s College of Business; Michael Peregrine, Partner at McDermott Will & Emery; and Thomas Tsai, MD, MPH, Surgeon and Health Policy Researcher in the Department of Surgery at Brigham and Women’s Hospital, and in the Department of Health Policy and Management at Harvard T.H. Chan School of Public Health.
